Dr Kaye-anne Lorraine Newton, MD | |
27 Heckel Rd Ste 205, Mc Kees Rocks, PA 15136 | |
(412) 777-4364 | |
(412) 777-4358 |
Full Name | Dr Kaye-anne Lorraine Newton |
---|---|
Gender | Female |
Speciality | Endocrinology |
Experience | 16 Years |
Location | 27 Heckel Rd Ste 205, Mc Kees Rocks, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659521094 | NPI | - | NPPES |
1033111410001 | Medicaid | PA | |
3810027520 | Medicaid | WV | |
0095175 | Medicaid | OH |
Facility Name | Location | Facility Type |
---|---|---|
Hartford Hospital | Hartford, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
A new study reveals that an enzyme linked with multiple disorders is also involved in the generation of toxic, neuron-killing protein fragments in Huntington's disease (HD). The research, published by Cell Press in the July 29 issue of Neuron, provides insight into Huntington's pathology and proposes new therapeutic strategies for this devastating incurable disease.
Researchers from Karolinska Institutet and Kancera AB have developed a molecule that makes cancer cells sensitive to radiotherapy. In a study published in Nature Communications, the researchers describe a new way to block cancer cells' ability to repair their DNA and thus stop the survival of cancer cells.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-CC5, an RNAi therapeutic targeting complement component C5.
Economists say taxing health benefits not only could raise billions per year for health care reform efforts, but also could make the system run better, NPR and KHN report.
› Verified 5 days ago
Entity Name | The William W Backus Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467517235 PECOS PAC ID: 0749170645 Enrollment ID: O20040316000739 |
News Archive
A new study reveals that an enzyme linked with multiple disorders is also involved in the generation of toxic, neuron-killing protein fragments in Huntington's disease (HD). The research, published by Cell Press in the July 29 issue of Neuron, provides insight into Huntington's pathology and proposes new therapeutic strategies for this devastating incurable disease.
Researchers from Karolinska Institutet and Kancera AB have developed a molecule that makes cancer cells sensitive to radiotherapy. In a study published in Nature Communications, the researchers describe a new way to block cancer cells' ability to repair their DNA and thus stop the survival of cancer cells.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-CC5, an RNAi therapeutic targeting complement component C5.
Economists say taxing health benefits not only could raise billions per year for health care reform efforts, but also could make the system run better, NPR and KHN report.
› Verified 5 days ago
Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
A new study reveals that an enzyme linked with multiple disorders is also involved in the generation of toxic, neuron-killing protein fragments in Huntington's disease (HD). The research, published by Cell Press in the July 29 issue of Neuron, provides insight into Huntington's pathology and proposes new therapeutic strategies for this devastating incurable disease.
Researchers from Karolinska Institutet and Kancera AB have developed a molecule that makes cancer cells sensitive to radiotherapy. In a study published in Nature Communications, the researchers describe a new way to block cancer cells' ability to repair their DNA and thus stop the survival of cancer cells.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-CC5, an RNAi therapeutic targeting complement component C5.
Economists say taxing health benefits not only could raise billions per year for health care reform efforts, but also could make the system run better, NPR and KHN report.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kaye-anne Lorraine Newton, MD 2 Northwestern Dr, Ste 100, Bloomfield, CT 06002-3480 Ph: (412) 777-4364 | Dr Kaye-anne Lorraine Newton, MD 27 Heckel Rd Ste 205, Mc Kees Rocks, PA 15136 Ph: (412) 777-4364 |
News Archive
A new study reveals that an enzyme linked with multiple disorders is also involved in the generation of toxic, neuron-killing protein fragments in Huntington's disease (HD). The research, published by Cell Press in the July 29 issue of Neuron, provides insight into Huntington's pathology and proposes new therapeutic strategies for this devastating incurable disease.
Researchers from Karolinska Institutet and Kancera AB have developed a molecule that makes cancer cells sensitive to radiotherapy. In a study published in Nature Communications, the researchers describe a new way to block cancer cells' ability to repair their DNA and thus stop the survival of cancer cells.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-CC5, an RNAi therapeutic targeting complement component C5.
Economists say taxing health benefits not only could raise billions per year for health care reform efforts, but also could make the system run better, NPR and KHN report.
› Verified 5 days ago
Dr. Adrienne Michele Young, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 27 Heckel Rd, Suite 205, Mc Kees Rocks, PA 15136 Phone: 412-771-0555 Fax: 412-771-0455 | |
Chhaganlal D Ladani, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 27 Heckel Rd Ste 101, Mc Kees Rocks, PA 15136 Phone: 412-777-4366 Fax: 412-777-4369 | |
Dr. Syed Tahir Ali, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 710 Thompson Ave, Mc Kees Rocks, PA 15136 Phone: 412-771-6462 Fax: 412-771-6423 | |
Dr. Alfred J Burgo, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 133 Church Hill Rd, Suite 2a, Mc Kees Rocks, PA 15136 Phone: 412-722-1003 Fax: 412-722-1024 | |
Dr. Danny Palmieri, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 133 Church Hill Rd, Suite 2a, Mc Kees Rocks, PA 15136 Phone: 412-722-1003 Fax: 412-722-1024 | |
Dr. Vibha Chikani, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 27 Heckel Rd Ste 101, Mc Kees Rocks, PA 15136 Phone: 412-777-4366 Fax: 412-777-4369 | |
Dr. Anisa Sultana Yunus, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 6000 Steubenville Pike, Suite 103, Mc Kees Rocks, PA 15136 Phone: 412-490-7440 Fax: 412-490-7443 |